Yi Lyu

Yi Lyu

Auto-generated profile, based on publicly available information

Yi Lyu

College of Food Science and Engineering, Nanjing University of Finance and Economics, Nanjing, 210023, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2018 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
YLYi Lyu
Yi Lyu
LWLei Wu
Lei Wu
FWFang Wang
Fang Wang
XSXinchun Shen
Xinchun Shen
DIngbo LinDIngbo Lin
DIngbo Lin
Dysbiosis, a broad spectrum of imbalance of the gut microbiota, may progress to microbiota dysfunction. Dysbiosis is linked to some human diseases, such as inflammation-related disorders and metabolic syndromes. However, the underlying mechanisms of the pathogenesis of dysbiosis remain elusive. Recent findings suggest that the microbiome and gut immune responses, like immunoglobulin A production, play critical roles in the gut homeostasis and function, and the progression of dysbiosis. In the past two decades, much progress has been made in better understanding of production of immunoglobulin A and its association with commensal microbiota. The present minireview summarizes the recent findings in the gut microbiota dysbiosis and dysfunction of immunoglobulin A induced by the imbalance of pathogenic bacteria and commensal microbiota. We also propose the potentials of dietary carotenoids, such as β-carotene and astaxanthin, in the improvement of the gut immune system maturation and immunoglobulin A production, and the consequent promotion of the gut health.Impact statement: The concept of carotenoid metabolism in the gut health has not been well established in the literature. Here, we review and discuss the roles of retinoic acid and carotenoids, including pro-vitamin A carotenoids and xanthophylls in the maturation of the gut immune system and IgA production. This is the first review article about the carotenoid supplements and the metabolites in the regulation of the gut microbiome. We hope this review would provide a new direction for the management of the gut microbiota dysbiosis by application of bioactive carotenoids and the metabolites.

1 August 2017 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
XGXin Guo
Xin Guo
LWLei Wu
Lei Wu
YLYi Lyu
Yi Lyu
WCWinyoo Chowanadisai
Winyoo Chowanadisai
SCStephen L. Clarke
Stephen L. Clarke
DIngbo LinDIngbo Lin
DIngbo Lin

1 March 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XCXiaozhou Cao
Xiaozhou Cao
YLYi Lyu
Yi Lyu
JNJunyu Ning
Junyu Ning
XTXiaozhi Tang
Xiaozhi Tang
XSXinchun Shen
Xinchun Shen

31 December 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
WZWenliang Zhao
Wenliang Zhao
YLYi Lyu
Yi Lyu
LXLing Xiong
Ling Xiong
LWLuanfeng Wang
Luanfeng Wang
FWFang Wang
Fang Wang
XSXinchun Shen
Xinchun Shen

7 June 2021 in Current Developments in Nutrition
Verified
Journal Article
Open access
PDF file
PLPeiran Lu
Peiran Lu
SWSiau Yen Wong
Siau Yen Wong
JCJIANMIN CHAI
JIANMIN CHAI
Paniz JasbiPaniz Jasbi
Paniz Jasbi
LWLei Wu
Lei Wu
DIngbo LinDIngbo Lin
DIngbo Lin
Zeaxanthin, an oxygenized carotenoid, exerts antioxidant properties in human nutrition and metabolism. Likely other carotenoids, zeaxanthin is poorly absorbed in the small intestine. The large portion of zeaxanthin reaches the colon and is not fully recovered in the colon. In this study, we aimed to investigate the association of zeaxanthin intake with the gut microbiome homeostasis and metabolomic responses in mice. Six-week-old male and female C57BL/6J wild type (WT), beta-carotene oxygenase 2 (BCO2) knockout mice were fed with AIN93M chow diets supplemented with or without zeaxanthin (0.02% w/w) for 10 weeks. At the termination of the study, mice were fasted for 3 hrs prior to euthanization. Cecal contents, colon, serum, feces, and other tissues were collected for laboratory assessments.16S rRNA sequencing and LC-MS/MS were performed for gut microbiota profiling and serum and fecal metabolomics analysis, respectively. Significant zeaxanthin accumulation occurred in BCO2 KO, but not WT mice. Zeaxanthin accumulation was associated with the alteration of colonic gut microbiota composition, for example, zeaxanthin-increased abundance in Lachnospiraceae, Proteobacteria, and Parabacteroides, indicating enhanced short-chain production, improved intestinal integrity, and anaerobic bacterial colonization. The results of fecal and serum metabolomics revealed that zeaxanthin significantly altered tyrosine metabolism, branched-chain fatty acid oxidation, fatty acid biosynthesis, and phospholipid biosynthesis, and suppressed levels of kynurenine and trimethylamine N-oxide (TMAO). The results suggested that zeaxanthin accumulation promotes gut microbiome homeostasis and alters the gut microbial metabolites as signals in stimulating the host-gut microbe interplay. USDA/NIFA 2021-67018-34023 and 2020-67017-30842.